Intravenous (IV) Therapy and Vein Access: Global Markets

Report Code: HLC046B

Publish Date: Aug 2010

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • In 2009, the total global intravenous therapy and vein access market reached nearly; $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
  • Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
  • The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
The objectives of the study are to present a comprehensive look at the intravenous (IV) therapy device and vein access market. There are eight general categories of IV therapy:
  • Ambulatory infusion pumps
  • Central venous access devices
  • Diabetes insulin-infusion pump
  • Enteral feeding pump and tubes
  • Implantable pumps
  • Large-volume infusion pumps
  • Peripheral venous access devices
  • Syringe infusion pumps
REASONS FOR STUDY
 
This BCC study is presented to increase the awareness of IV therapy devices and vein access. The study analyzes the IV therapy market from different standpoints and addresses issues and trends affecting IV therapy administration. IV therapy and vein access device manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative devices. Because of the evolving nature of this important area of medicine, executives of IV therapy devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of IV therapy.
 
SCOPE OF STUDY
 
This report is a comprehensive business tool designed to provide an in-depth look at the market for IV therapy and vein access. The geographic scope of the report is the global. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.
 
Categories discussed in the report include:
  • Ambulatory infusion pumps
  • Central venous access devices
  • Diabetes insulin-infusion pump
  • Enteral feeding pump and tubes
  • Implantable pumps
  • Large-volume infusion pumps
  • Peripheral venous access devices
  • Syringe infusion pumps.
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2009 to 2014, and assessing the competitors and competitor market shares.
 
METHODOLOGY AND INFORMATIO SOURCES
 
The information and analysis presented in this BCC report are based on extensive firsthand interviews with primary executives, product managers, and clinical specialists in the intravenous infusion and vein access arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the administration of intravenous therapy and vein access. 
 
Key information from published literature was used to conduct interviews with over 22 industry participants to validate and obtain expert opinions on current and future trends in the IV therapy and vein access industry. Interviews were the primary basis for development of market size. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulating market projections.
 
All market data pertain to the global market at the manufacturer’s level. Data are expressed in current U.S. dollars. The base year was 2009. Historical data are provided for 2008 and forecast data are provided for 2014. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2009 base year.
 
ANALYST CREDENTIALS
 
Mary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industry for the last 18 years. She has completed several in-depth studies on various medical topics requiring both medical expertise and excellent knowledge of the pharmaceutical industry. Ms. Crandall has extensive knowledge in the medical field, has a MS in psychology, and is currently working on a PhD. 
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Intravenous (IV) Therapy and Vein Access: Global Markets152Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: INDUSTRY OVERVIEW107Free
Chapter- 4: TOTAL MARKET SIZE AND GROWTH6Free
Chapter- 5: TECHNOLOGY ANALYSIS2Free
Chapter- 6: MARKET ANALYSIS3Free
Chapter- 7: COMPETITIVE ANALYSIS2Free
Chapter- 8: MARKET OUTLOOK1Free
Chapter- 9: C. CRAMER & CO. GMBH18Free
Chapter- 10: APPENDIX6Free
Published - Aug-2006| Analyst - Mary Anne Crandall| Code - HLC046A

Report Highlights

  • U.S. market revenues for IV therapy and vein access were worth more than $4.6 billion in 2005. At an average annual growth rate (AAGR) of 4.2%, the market will reach almost $5.7 billion by 2010.
  • The market is broken down by ambulatory infusion pumps, enteral feeding pumps, peripheral venous access devices, and syringe infusion pumps. Ambulatory fusion pumps and peripheral venous access devices both held approximately 30% of the market share in 2005. Fusion pumps will maintain the majority of the market through the forecast period, holding a 29% share in 2010.
  • The fastest growing market sector will be syringe infusion pumps, which will have an AAGR of approximately 6.8% through the forecast period.

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Flame Retardant Chemicals: Technologies and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - CHM014Q

The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.

Biorefinery Products: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - EGY117D

The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

Electric Vehicle Charging: Infrastructure and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - FCB045B

The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Intravenous (IV) Therapy and Vein Access: Global Markets
Customize Report